Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Silver Creek Pharmaceuticals Inc.
DescriptionInsulin-like growth factor-1 (IGF-1) modified using Smart Growth Factor technology
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentPreclinical
Standard IndicationMyocardial infarction (MI)
Indication DetailsTreat myocardial infarction (MI)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today